| Type : |
Journal |
| Internett-koblingen : |
https://pubmed.ncbi.nlm.nih.gov/18032138/ |
|
| Forskerteamet : |
Nutley - Roche Laboratories |
| Forfattere : |
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K. |
| Tittel : |
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. |
| Nummer : |
J Am Pharm Assoc ; 47, 6; 747-755. 2007 |
|
| Nivå of Evidence : |
|
| fysisk stabilitet : |
|
| kjemisk stabilitet : |
|
| andre metoder : |
|
| Kommentarer : |
|
Lister
 Oseltamivir
|
 |
 |
 |
 |
450 mg
Tamiflu® |
| Kirsebærsirup sirup |
>> 30 ml |
|
23-27°C |
 |
| 5 |
 |
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
| Kirsebærsirup sirup |
>> 30 ml |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
 |
|
450 mg
Tamiflu® |
| Kirsebærsirup sirup |
>> 30 ml |
|
23-27°C |
|
| 5 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
| Kirsebærsirup sirup |
>> 30 ml |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
